As of 2025-10-31, the Fair Value of Entheon Biomedical Corp (ENBI.CN) is -0.14 CAD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.10 CAD, the upside of Entheon Biomedical Corp is -247.59%.
With the market price of 0.10 CAD and our fair value calculation, Entheon Biomedical Corp (ENBI.CN) is not a good investment. Investing in ENBI.CN stocks now will result in a potential loss of 247.59%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-11-30 | 2021-11-30 | 2022-11-30 | 2023-11-30 | 2024-11-30 | 5Y Avg | |
| Net income | -4.38 | -8.89 | -8.52 | -0.30 | -0.32 | -4.48 |
| YoY growth | -2,885.07% | -102.82% | 4.12% | 96.48% | -5.97% | -578.65% |
| Market Cap (mil) | 1.32 |
| P/E | |
| Forward P/E |
| EPS | -0.03 |
| Avg earnings growth rate | -578.65% |
| TTM earnings | -0.39 |